US 7732167
Interferon-α/β binding fusion proteins and therapeutic uses thereof
granted A61KA61K38/00
Quick answer
US patent 7732167 (Interferon-α/β binding fusion proteins and therapeutic uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00